LINC00857 regulated by ZNF460 enhances the expression of CLDN12 by sponging miR-150-5p and recruiting SRSF1 for alternative splicing to promote epithelial-mesenchymal transformation of pancreatic adenocarcinoma cells

References

• Capasso M, Franceschi M, Rodriguez-Castro KI, et al. Epidemiology and risk factors of pancreatic cancer. Acta Biomed. 2018;89:141–146.
   PubMedGoogle Scholar
• Tan E, Song J, Lam S, et al. Postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: a systematic review and meta-analysis. Int J Surg. 2019;72:59–68.
   PubMed Web of Science ®Google Scholar
• Henrikson NB, Aiello Bowles EJ, Blasi PR, et al. Screening for pancreatic cancer: updated evidence report and systematic review for the US preventive services task force. Jama. 2019;322(5):445–454.
   PubMed Web of Science ®Google Scholar
• Sánchez Acedo P, Herrera Cabezón J, Zazpe Ripa C, et al. Survival, morbidity and mortality of pancreatic adenocarcinoma after pancreaticoduodenectomy with a total mesopancreas excision. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva. 2019;111:609–614.
   PubMed Web of Science ®Google Scholar
• Parmar A, Chaves-Porras J, Saluja R, et al. Adjuvant treatment for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. Crit Rev Oncol Hematol. 2020;145:102817.
   PubMed Web of Science ®Google Scholar
• Motoi F, Unno M. Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma. Jpn J Clin Oncol. 2020;50(5):483–489.
   PubMed Web of Science ®Google Scholar
• Song Y, Zou L, Li J, et al. LncRNA SNHG8 promotes the development and chemo-resistance of pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci. 2018;22:8161–8168.
   PubMed Web of Science ®Google Scholar
• Jin X, Ye L, Lin M, et al. lncRNA-CCHE1 is involved in migration and invasion but not in proliferation of pancreatic adenocarcinoma cells possibly by interacting with ROCK1. Oncol Lett. 2019;18:1218–1224.
   PubMed Web of Science ®Google Scholar
• Wang G, Li Z, Zhao Q, et al. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway. Oncol Rep. 2014;31(4):1839–1845.
   PubMed Web of Science ®Google Scholar
• Jia M, Jiang L, Wang YD, et al. lincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial-mesenchymal transition. Hepatol Res. 2016;46(11):1137–1144.
   PubMed Web of Science ®Google Scholar
• Li Q, Lei C, Lu C, et al. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2. Cell Death Dis. 2019;10(10):698.
   PubMed Web of Science ®Google Scholar
• Xia C, Zhang XY, Liu W, et al. LINC00857 contributes to hepatocellular carcinoma malignancy via enhancing epithelial-mesenchymal transition. J Cell Biochem. 2018.
   Web of Science ®Google Scholar
• Wang L, He Y, Liu W, et al. Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer. Oncotarget. 2016;7(10):11487–11499.
   PubMedGoogle Scholar
• Zhao R, Ni J, Lu S, et al. CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma. Aging (Albany NY). 2019;11(19):8484–8501.
   PubMedGoogle Scholar
• Wang L, Cao L, Wen C, et al. LINC00857 regulates lung adenocarcinoma progression, apoptosis and glycolysis by targeting miR-1179/SPAG5 axis. Hum Cell. 2020;33(1):195–204.
   PubMed Web of Science ®Google Scholar
• Yang X, Coulombe-Huntington J, Kang S, et al. Widespread expansion of protein interaction capabilities by alternative splicing. Cell. 2016;164(4):805–817.
   PubMed Web of Science ®Google Scholar
• Chabot B, Shkreta L. Defective control of pre-messenger RNA splicing in human disease. J Cell Biol. 2016;212(1):13–27.
   PubMed Web of Science ®Google Scholar
• Climente-González H, Porta-Pardo E, Godzik A, et al. The functional impact of alternative splicing in cancer. Cell Rep. 2017;20(9):2215–2226.
   PubMed Web of Science ®Google Scholar
• Pradella D, Naro C, Sette C, et al. EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression. Mol Cancer. 2017;16:8.
   PubMed Web of Science ®Google Scholar
• Chang HL, Lin JC. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism. Biochim Biophys Acta Mol Cell Res. 2019;1866(12):118550.
   PubMed Web of Science ®Google Scholar
• Rong MH, Zhu ZH, Guan Y, et al. Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma. PeerJ. 2020;8:e8380.
   PubMed Web of Science ®Google Scholar
• Yin K, Zhang Y, Zhang S, et al. Using weighted gene co-expression network analysis to identify key modules and hub genes in tongue squamous cell carcinoma. Medicine (Baltimore). 2019;98(37):e17100.
   PubMed Web of Science ®Google Scholar
• Liu A, Huang C, Cai X, et al. Twist promotes angiogenesis in pancreatic cancer by targeting miR-497/VEGFA axis. Oncotarget. 2016;7(18):25801–25814.
   PubMedGoogle Scholar
• Sun L, Feng L, Cui J. Increased expression of claudin-12 promotes the metastatic phenotype of human bronchial epithelial cells and is associated with poor prognosis in lung squamous cell carcinoma. Exp Ther Med. 2019;17:165–174.
   PubMed Web of Science ®Google Scholar
• Zhang W, Lu Y, Li X, et al. IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation. J Exp Clin Cancer Res. 2019;38(1):296.
   PubMedGoogle Scholar
• Tian X, He Y, Han Z, et al. The cytoplasmic expression of CLDN12 predicts an unfavorable prognosis and promotes proliferation and migration of osteosarcoma. Cancer Manag Res. 2019;11:9339–9351.
   PubMed Web of Science ®Google Scholar
• Luo X, He S, Hu Y, et al., Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology. 2019;42:21–29.
   PubMed Web of Science ®Google Scholar
• Li J, Cheng D, Zhu M, et al. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer. Theranostics. 2019;9(1):179–195.
   PubMed Web of Science ®Google Scholar
• Li K, Huang F, Li Y, et al. Stabilization of oncogenic transcripts by the IGF2BP3/ELAVL1 complex promotes tumorigenicity in colorectal cancer. Am J Cancer Res. 2020;10:2480–2494.
   PubMed Web of Science ®Google Scholar
• Anczuków O, Akerman M, Cléry A, et al. SRSF1-regulated alternative splicing in breast cancer. Mol Cell. 2015;60(1):105–117.
   PubMed Web of Science ®Google Scholar
• Sheng J, Zhao Q, Zhao J, et al. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance. EBioMedicine. 2018;38:113–126.
   PubMed Web of Science ®Google Scholar
• Zhou X, Wang R, Li X, et al. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B. J Clin Invest. 2019;129(2):676–693.
   PubMed Web of Science ®Google Scholar
• Lee Y, Rio DC. Mechanisms and regulation of alternative pre-mRNA splicing. Annu Rev Biochem. 2015;84(1):291–323.
   PubMedGoogle Scholar
• Vizcaíno C, Mansilla S, Portugal J. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther. 2015;152:111–124.
   PubMed Web of Science ®Google Scholar
• Raghuram V, Weber S, Raber J, et al. Assessment of mutations in KCNN2 and ZNF135 to patient neurological symptoms. Neuroreport. 2017;28(7):375–379.
   PubMed Web of Science ®Google Scholar
• Dai J, Li Y, Ji C, et al. Characterization of two novel KRAB-domain-containing zinc finger genes, ZNF460 and ZNF461, on human chromosome 19q13.1–>q13.4. Cytogenet Genome Res. 2003;103(1–2):74–78.
   PubMed Web of Science ®Google Scholar
• Zhu W, Gao W, Deng Y, et al. Identification and development of long non-coding RNA associated regulatory network in pancreatic adenocarcinoma. Onco Targets Ther. 2020;13:12083–12096.
   PubMed Web of Science ®Google Scholar
• Shi X, Zhao Y, He R, et al. Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma. Oncotarget. 2018;9(36):24248–24259.
   PubMedGoogle Scholar
• Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–914.
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391–407.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu T, Wang M, et al. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer. J Cell Biochem. 2020;121(2):946–953.
   PubMed Web of Science ®Google Scholar